XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

Sector: Medicinal Chemicals And Botanical Products Region: Israel

: | Tel Aviv Stock Exchange: XTLB | Nasdaq: XTLB

Similar to: Cyanotech Corp., SkyePharma Plc

XTL Biopharmaceuticals Ltd. is engaged in the acquisition, development, and commercialization of proprietary and pharmaceutical products. It also develops therapeutics such as erythropoietin program, SAM-101, and diversity oriented synthesis program. These medical products are created for the treatment of multiple myeloma, schizophrenia, and hepatitis C. The company was founded on March 9, 1993 and is headquartered in Herzliya, Israel.

News & Analysis

You may also be interested in: